ArticleInternational journal of clinical oncology2015

First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.

Ying Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.